Starboard says Depomed should consider selling itself
April 08, 2016 at 10:43 AM EDT
New York hedge fund Starboard Value says DepoMed should consider selling itself, in a letter to the drug maker’s board a day after disclosing a near 10% stake in the maker of pain drugs.
